What Sio Capital Management, LLC reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1482416 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 173.6K |
| +72.0% |
| $49.1M |
| 8.1% |
MMSMaximus, Inc. | 715.3K | −7.0% | $38.5M | 6.4% |
ALLOAllogene Therapeutics, Inc. | 13.3M | New | $27.7M | 4.6% |
GMEDGlobus Medical Inc | 301.8K | New | $23.8M | 3.9% |
GSKGSK plc | 436.7K | +13.2% | $22.9M | 3.8% |
TYRATyra Biosciences, Inc. | 695.3K | +14.8% | $22.2M | 3.7% |
WAYWaystar Holding Corp. | 925.8K | −43.6% | $19M | 3.1% |
| 1.2M | New | $18.2M | 3% |
IDYAIDEAYA Biosciences, Inc. | 480.4K | New | $17.9M | 3% |
ORKAOruka Therapeutics, Inc. | 177.1K | +33.7% | $16.9M | 2.8% |
CICigna Group | 57.8K | New | $15.9M | 2.6% |
SNYSanofi | 364.2K | +52.0% | $15.5M | 2.6% |
ICLRIcon PLC | 88.2K | −71.2% | $15.3M | 2.5% |
VTRSViatris Inc | 954.3K | New | $15.2M | 2.5% |
CCRNCross Country Healthcare, Inc. | 1.1M | ±0% | $14.5M | 2.4% |
RAPPRapport Therapeutics, Inc. | 307.7K | −16.1% | $12.8M | 2.1% |
ABTAbbott Laboratories | 128.7K | −31.0% | $11.7M | 1.9% |
CELCCelcuity Inc. | 110K | −43.2% | $11.5M | 1.9% |
ZBHZimmer Biomet Holdings, Inc. | 131.4K | +109.9% | $11.3M | 1.9% |
REGNRegeneron Pharmaceuticals, Inc. | 18K | New | $11.2M | 1.9% |
BMYBristol Myers Squibb Co | 193.5K | New | $11.1M | 1.8% |
MDTMedtronic plc | 142.5K | New | $11.1M | 1.8% |
VIRVir Biotechnology, Inc. | 1.1M | −28.2% | $11M | 1.8% |
SENSSenseonics Holdings, Inc. | 1.6M | +1,275.6% | $9M | 1.5% |
EYPTEyePoint, Inc. | 623.1K | −13.7% | $8.9M | 1.5% |
HELPHelus Pharma Inc. | 1.3M | New | $8.6M | 1.4% |
ANIPANI Pharmaceuticals Inc | 97.3K | −63.4% | $8.1M | 1.3% |
TARAProtara Therapeutics, Inc. | 1.9M | −2.4% | $7.3M | 1.2% |
RLMDRelmada Therapeutics, Inc. | 1M | +4.0% | $6.9M | 1.1% |
TNGXTango Therapeutics, Inc. | 208.5K | New | $6.5M | 1.1% |
AQSTAquestive Therapeutics, Inc. | 1.5M | −22.7% | $6.2M | 1% |
DNTHDianthus Therapeutics, Inc. | 59.3K | −84.0% | $5.8M | 1% |
SIONSionna Therapeutics, Inc. | 127.8K | −56.6% | $5.6M | 0.9% |
OCULOcular Therapeutix, Inc | 539.5K | −44.3% | $5.3M | 0.9% |
ZBIOZenas BioPharma, Inc. | 208.6K | −37.1% | $5.3M | 0.9% |
DRUGBright Minds Biosciences Inc. | 74K | −14.1% | $5.2M | 0.9% |
OKUROnKure Therapeutics, Inc. | 1.1M | ±0% | $4.9M | 0.8% |
SVRASavara Inc | 617.7K | +0.6% | $3.8M | 0.6% |
PMVPPMV Pharmaceuticals, Inc. | 2.6M | −14.4% | $3.5M | 0.6% |
AVAHAveanna Healthcare Holdings, Inc. | 369K | New | $3.2M | 0.5% |
OVIDOvid Therapeutics Inc. | 1M | −19.7% | $2.7M | 0.4% |
IMNMImmunome Inc. | 124.2K | −24.8% | $2.6M | 0.4% |
| 75K | New | $2.6M | 0.4% |
ANTXAN2 Therapeutics, Inc. | 529.9K | −19.4% | $2.6M | 0.4% |
SERSerina Therapeutics, Inc. | 1M | ±0% | $1.9M | 0.3% |
ALGSAligos Therapeutics, Inc. | 327.2K | ±0% | $1.9M | 0.3% |
IBIOiBio, Inc. | 904.3K | ±0% | $1.6M | 0.3% |
XLOXilio Therapeutics, Inc. | 152.5K | ±0% | $1.5M | 0.2% |
AORTArtivion, Inc. | 48.5K | New | $1.1M | 0.2% |
BBOTBridgeBio Oncology Therapeutics, Inc. | 130.6K | ±0% | $995.4K | 0.2% |
TELATELA Bio, Inc. | 636.3K | ±0% | $477.2K | 0.1% |
ADGMAdagio Medical Holdings, Inc. | 699K | −45.8% | $455.5K | 0.1% |
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp | 82.8K | New | $251.6K | 0.1% |
ENVBEnveric Biosciences, Inc. | 180K | New | $248.4K | 0.1% |
MODDModular Medical, Inc. | 26.2K | ±0% | $117.9K | 0.1% |
QTIQT Imaging Holdings, Inc. | 15.2K | New | $62K | 0.1% |
RCKTWRocket Pharmaceuticals, Inc. | 400K | ±0% | $1.5K | 0.1% |
HUMAWHumacyte, Inc. | 50K | ±0% | $477 | 0.1% |
